LOGSX Live Oak Health Sciences Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Amgen (NASDAQ:AMGN), McKesson Corp (NYSE:MCK), Exelixis (NASDAQ:EXEL).

The investment seeks long-term capital growth. The fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. It will invest at least 80% of its net assets, under normal circumstances, in equity securities of health science companies. The fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in equity REITs, common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund.

The average market capitalization across the Live Oak Health Sciences MF is 124.36B. The market cap for tickers in the group ranges from 6.53B to 651.25B. JNJ holds the highest valuation in this group at 651.25B. The lowest valued company is LNTH at 6.53B.

The average weekly volume growth across all stocks in the Live Oak Health Sciences MF was 11%. For the same stocks of the MF, the average monthly volume growth was -24% and the average quarterly volume growth was -42%